This milestone reflects Longzen's commitment to manufacturing excellence and providing high-quality, accessible treatment for Type 2 Diabetes patients.
A major win for our R&D and regulatory teams!
Big News: Longzen's Teneligliptin Achieves Class A Status!
We are proud to announce that our Teneligliptin has officially received Class A regulatory approval.
This milestone reflects Longzen's commitment to manufacturing excellence and providing high-quality, accessible treatment for Type 2 Diabetes patients.
This milestone reflects Longzen's commitment to manufacturing excellence and providing high-quality, accessible treatment for Type 2 Diabetes patients.